BNXT — BioNxt Solutions Cashflow Statement
0.000.00%
Last trade - 00:00- CA$31.23m
- CA$36.26m
- CA$0.37m
Annual cashflow statement for BioNxt Solutions, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.67 | -16.9 | -20.6 | -12.4 | -7.72 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 2.9 | 6.12 | 8.19 | 6.88 | 2.03 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.18 | 0.026 | -0.419 | -0.56 | 0.328 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -3.69 | -10.2 | -12.2 | -6.23 | -5.17 |
| Capital Expenditures | -0.119 | -0.156 | -0.452 | -0.004 | -0.201 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.343 | 0 | -4.86 | 0 | 0.302 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.462 | -0.156 | -5.31 | -0.004 | 0.101 |
| Financing Cash Flow Items | -0.076 | 0 | -0.59 | -0.472 | -0.448 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.08 | 12.7 | 16.2 | 5.02 | 5.29 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.07 | 2.29 | -1.23 | -1.22 | 0.227 |